タイトル | Conformational flexibility and inhibitor binding to unphosphorylated interleukin-1 receptor-associated kinase 4 (IRAK4). |
---|
ジャーナル・号・ページ | J. Biol. Chem., Vol. 294, Page 4511-4519, Year 2019 |
---|
掲載日 | 2018年8月19日 (構造データの登録日) |
---|
著者 | Wang, L. / Ferrao, R. / Li, Q. / Hatcher, J.M. / Choi, H.G. / Buhrlage, S.J. / Gray, N.S. / Wu, H. |
---|
リンク | J. Biol. Chem. / PubMed:30679311 |
---|
手法 | X線回折 |
---|
解像度 | 1.401 - 2.61 Å |
---|
構造データ | PDB-6eg9: IRAK4 in complex with Ponatinib 手法: X-RAY DIFFRACTION / 解像度: 2.414 Å PDB-6ega: IRAK4 in complex with a type II inhibitor 手法: X-RAY DIFFRACTION / 解像度: 2.512 Å PDB-6egd: Crystal structure of the unphosphorylated IRAK4 kinase domain Bound to a type I inhibitor 手法: X-RAY DIFFRACTION / 解像度: 2.1 Å PDB-6ege: Crystal structure of the unphosphorylated IRAK4 kinase domain Bound to a type I inhibitor 手法: X-RAY DIFFRACTION / 解像度: 1.401 Å PDB-6egf: Crystal structure of the inactive unphosphorylated IRAK4 kinase domain bound to AMP-PNP 手法: X-RAY DIFFRACTION / 解像度: 2.61 Å |
---|
化合物 | ChemComp-0LI: 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzam / ポナチニブ / 薬剤*YM
ChemComp-J8A: 3-{2-[(cyclopropanecarbonyl)amino][1,3]thiazolo[5,4-b]pyridin-5-yl}-N-{4-[(piperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide
ChemComp-J87: N-[2-methoxy-4-(morpholin-4-yl)phenyl]-2-(pyridin-3-yl)-1,3-thiazole-5-carboxamide
ChemComp-DL1: N-[2-methoxy-4-(morpholin-4-yl)phenyl]-6-(1H-pyrazol-5-yl)pyridine-2-carboxamide
ChemComp-ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER / AMP-PNP / AMP-PNP, エネルギー貯蔵分子類似体*YM
|
---|
由来 | - homo sapiens (ヒト)
|
---|
キーワード | TRANSFERASE/TRANSFERASE INHIBITOR / Inhibitor / complex / TRANSFERASE / TRANSFERASE-TRANSFERASE INHIBITOR complex / Kinase / Unphosphorylated / Inactive / SIGNALING PROTEIN |
---|